Document Detail


Optimizing wound healing in the face after laser abrasion.
MedLine Citation:
PMID:  11862176     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Laser resurfacing is a popular procedure to improve the physical signs of photoaging. In addition to improvements in treatment modalities, optimizing posttreatment regimens will enhance patient care. OBJECTIVE: Our purpose was to evaluate the efficacy of two forms of wound care for the face after laser abrasion. METHODS: Forty-two patients received full-face laser resurfacing at two clinics by using either the UltraPulse carbon dioxide (CO(2)) laser (Coherent Laser Corp, Palo Alto, Calif) alone or followed by an erbium:YAG laser (Derma-20, ESC Sharplan, Inc, Needham, Mass) and/or a blended CO(2)/Er:YAG laser (Derma-K, ESC Sharplan) or a variable pulse erbium:YAG laser (Contour, Sciton Laser Corp, Palo Alto). Twenty-one patients were randomly assigned to a postoperative regimen including Silon-TSR (Bio Med Sciences, Inc, Allentown, Pa) for the first 2 to 3 days after laser resurfacing, followed by Aquaphor ointment (Beiersdorf, Charlotte, NC) to complete the first 2 weeks. The other 21 patients received the resurfacing recovery system (RRS, Neutrogena, Los Angeles, Calif) following a specific regimen. The system includes Fibracol wound dressing (Johnson & Johnson, Skillman, NJ) for 2 days, followed by a hydrogel dressing for 1 to 2 days, followed by an ointment to complete the first 2 weeks. Patients were evaluated for wound healing on days 2, 3, 6-10, 14-16, and 28-30. The skin was swabbed for colonization at every visit to determine the quantity of bacteria throughout the healing process. RESULTS: Ninety percent of patients in both groups experienced either "no pain" or "minimal pain" during the first 3 days. Total bacterial counts peaked on days 3 and 6 in the patients managed with the RRS and the Silon-TSR/Aquaphor regimen, respectively. The average day at which patients did not require a dressing was 3.0 days in the group managed with the RRS and 3.7 days in the group managed with the Silon-TSR/Aquaphor dressing regimen (P < or =.05). The average day of complete epithelial regeneration was significantly shorter at 6.3 days using the RRS compared with 7.4 days for patients using the Silon-TSR/Aquaphor regimen (P < or =.02). There was no difference in infection, adverse sequelae, exudate management, or pain in either group. CONCLUSION: Healing was optimized in patients using the RRS after laser resurfacing.
Authors:
Mitchel P Goldman; Thomas L Roberts; Greg Skover; John T Lettieri; Richard E Fitzpatrick
Related Documents :
21879626 - Managing antidepressants in primary care: physicians' treatment modifications.
21877456 - Motivational interviewing in dialysis adherence study (midas).
21973046 - Autologous bone marrow cell therapy for patients with peripheral arterial disease: a me...
21831726 - International phase iii trial of liprotamase efficacy and safety in pancreatic-insuffic...
19495406 - Comparison of the efficacy of the cervex brush and the extended-tip wooden spatula with...
2944926 - Clinical prediction of outcome and lithium response in bipolar affective disorder.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  46     ISSN:  0190-9622     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-02-25     Completed Date:  2002-03-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  399-407     Citation Subset:  IM    
Affiliation:
Dermatology Associates of San Diego County, Inc., 9850 Genesee Ave. Suite 480, La Jolla, CA 92037, USA. mgderm@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bandages
Humans
Laser Therapy*
Ointments
Postoperative Care
Prospective Studies
Regeneration
Rhytidoplasty*
Single-Blind Method
Skin Aging*
Wound Healing*
Wound Infection / etiology
Chemical
Reg. No./Substance:
0/Ointments

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subungual myxoid cysts: clinical manifestations and response to therapy.
Next Document:  Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus derma...